Search Tag: remdesivir

ICU Management

Solidarity Trial Interim Results: Antiviral Drugs in Hospitalised COVID-19 Patients

2021 16 Feb

Mortality trials of four antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon beta-1a were recommended by the World Health Organization (WHO) to evaluate their effect in patients hospitalised with COVID-19. In March 2020, the WHO began a large international trial that included hospital inpatients to evaluate the effects... Read more

ICU Management

Treating Early COVID-19 Infection

2020 14 Nov

There have been over 47 million cases of COVID-19 globally and 1.2 million deaths. According to Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), the treatment of patients with early COVID-19 infection requires urgent focus. Treating these patients early in the course of infection could help speed up their... Read more

Executive Health Management

Lottery for Insufficient Drugs Allocation

2020 29 Jun

One solution to the problem of scarce medications allocation, which has been exacerbated by the COVID-19 pandemic, can be the implementation of a centralised lottery system, an article in JAMA argues.   You might also like: EMA Fast-Tracking Procedures for COVID-19 Medicines   The authors (White and Angus 2020) take as an example... Read more

Executive Health Management

Potential COVID-19 Treatments: Some In, Some Out

2020 27 May

The UK health ministry has announced that the antiviral drug remdesivir would be made available to selected COVID-19 patients while the World Health Organization (WHO) is putting the hydroxychloroquine/chloroquine arm within the COVID-19 Solidarity Trial on hold.   You may also like : From Hydroxychloroquine and Remdesivir to Plasma Administration... Read more

ICU Management

Volume 20 - Issue 1, 2020

2020 19 May

Change content default value Read more

ICU Management

From Hydroxychloroquine and Remdesivir to Plasma Administration

2020 19 May

Clinicians are faced with a serious disease with no effective therapy. Several options are being considered to treat COVID-19, but how promising are these drugs? A  number of colleagues and friends from outside the hospital have asked me whether they should take hydroxychloroquine for their COVID-19. A friend asked me whether he should... Read more

Cardiology Management

Remdesivir in Adults With Severe COVID-19

2020 06 May

The search for a drug to treat patients with coronavirus disease (COVID-19) has created an interest in a relatively new antiviral drug called remdesivir. Although the majority of patients who acquire coronavirus only develop a self-limited mild illness, around 10-20% of patients develop severe pneumonia and respiratory distress that requires ICU care,... Read more